ARID1A and cancer: For example, ARID1A (AT-rich interaction domain 1A)-deficient cancer cells, of which enhanced SLC7A11 expression by ARID1A-mediated chromatin remodeling disappears, are more susceptible to inhibition of the antioxidant glutathione due to excessive amounts of ROS-triggered apoptosis (89).